These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8662840)

  • 1. Induced and spontaneous mutations at Ser202 of carboxypeptidase E. Effect on enzyme expression, activity, and intracellular routing.
    Varlamov O; Leiter EH; Fricker L
    J Biol Chem; 1996 Jun; 271(24):13981-6. PubMed ID: 8662840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxypeptidase E activity is deficient in mice with the fat mutation. Effect on peptide processing.
    Fricker LD; Berman YL; Leiter EH; Devi LA
    J Biol Chem; 1996 Nov; 271(48):30619-24. PubMed ID: 8940036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired prohormone convertases in Cpe(fat)/Cpe(fat) mice.
    Berman Y; Mzhavia N; Polonskaia A; Devi LA
    J Biol Chem; 2001 Jan; 276(2):1466-73. PubMed ID: 11038363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glu300 of rat carboxypeptidase E is essential for enzymatic activity but not substrate binding or routing to the regulated secretory pathway.
    Qian Y; Varlamov O; Fricker LD
    J Biol Chem; 1999 Apr; 274(17):11582-6. PubMed ID: 10206965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trafficking of mutant carboxypeptidase E to secretory granules in a beta-cell line derived from Cpe(fat)/Cpe(fat) mice.
    Cawley NX; Rodriguez YM; Maldonado A; Loh YP
    Endocrinology; 2003 Jan; 144(1):292-8. PubMed ID: 12488357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of a phorbol ester on carboxypeptidase E in cultured astrocytes and AtT-20 cells, a neuroendocrine cell line.
    Klein RS; Fricker LD
    J Neurochem; 1993 May; 60(5):1615-25. PubMed ID: 8473886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel prohormone sorting signal-binding site on carboxypeptidase E, a regulated secretory pathway-sorting receptor.
    Zhang CF; Snell CR; Loh YP
    Mol Endocrinol; 1999 Apr; 13(4):527-36. PubMed ID: 10194759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of incompletely processed potential carboxypeptidase E substrates from CpEfat/CpEfat mice.
    Bures EJ; Courchesne PL; Douglass J; Chen K; Davis MT; Jones MD; McGinley MD; Robinson JH; Spahr CS; Sun J; Wahl RC; Patterson SD
    Proteomics; 2001 Jan; 1(1):79-92. PubMed ID: 11680901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity.
    Naggert JK; Fricker LD; Varlamov O; Nishina PM; Rouille Y; Steiner DF; Carroll RJ; Paigen BJ; Leiter EH
    Nat Genet; 1995 Jun; 10(2):135-42. PubMed ID: 7663508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of carboxypeptidase E from cultured astrocytes and from AtT-20 cells, a neuroendocrine cell line: implications for neuropeptide biosynthesis.
    Klein RS; Das B; Fricker LD
    J Neurochem; 1992 Jun; 58(6):2011-8. PubMed ID: 1573389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranslational processing of carboxypeptidase E, a neuropeptide-processing enzyme, in AtT-20 cells and bovine pituitary secretory granules.
    Fricker LD; Devi L
    J Neurochem; 1993 Oct; 61(4):1404-15. PubMed ID: 8376994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-cell lines derived from transgenic Cpe(fat)/Cpe(fat) mice are defective in carboxypeptidase E and proinsulin processing.
    Varlamov O; Fricker LD; Furukawa H; Steiner DF; Langley SH; Leiter EH
    Endocrinology; 1997 Nov; 138(11):4883-92. PubMed ID: 9348219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary.
    Song L; Fricker LD
    J Biol Chem; 1995 Oct; 270(42):25007-13. PubMed ID: 7559630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinsulin targeting to the regulated pathway is not impaired in carboxypeptidase E-deficient Cpefat/Cpefat mice.
    Irminger JC; Verchere CB; Meyer K; Halban PA
    J Biol Chem; 1997 Oct; 272(44):27532-4. PubMed ID: 9346885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminal region of carboxypeptidase E involved in membrane binding is distinct from the region involved with intracellular routing.
    Varlamov O; Fricker LD
    J Biol Chem; 1996 Mar; 271(11):6077-83. PubMed ID: 8626393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxypeptidase E (CPE) deficiency in mice with the fat mutation have reduced stomach function.
    Gomez P; Hallberg L; Greeley GH
    Proc Soc Exp Biol Med; 1999 Jan; 220(1):52-3. PubMed ID: 9893169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of procarboxypeptidase E into carboxypeptidase E occurs in secretory vesicles.
    Song L; Fricker L
    J Neurochem; 1995 Jul; 65(1):444-53. PubMed ID: 7790890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation and localization of carboxypeptidase D and carboxypeptidase E in human and mouse β-cells.
    Chu KY; Briggs MJ; Albrecht T; Drain PF; Johnson JD
    Islets; 2011; 3(4):155-65. PubMed ID: 21628999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pro region is not required for the expression or intracellular routeing of carboxypeptidase E.
    Song L; Fricker LD
    Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):265-71. PubMed ID: 9173892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of carboxypeptidase E. Effect of Ca2+ on enzyme activity and stability.
    Nalamachu SR; Song L; Fricker LD
    J Biol Chem; 1994 Apr; 269(15):11192-5. PubMed ID: 8157647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.